ALT
Altimmune Inc
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 85.85%
Annual Growth
5 years average annual growth
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. The Company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). The Company has completed the MOMENTUM Phase II obesity trial and is being studied in the IMPACT Phase IIb MASH trial. It is also developing HepTcell, an immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus (HBV). The Company has completed the enrollment in its Phase II clinical trial of HepTcell. Its product candidates are based on its proprietary platform technologies, such as EuPort-based Peptide Technology and Synthetic Peptide Technology-Densigen. The Company’s wholly owned subsidiaries include Altimmune, LLC, Altimmune UK, Limited, Spitfire Pharma, LLC and Altimmune AU Pty, Limited.
📈 Performance
Price History*
-84.31%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$8.68
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ALT
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
34 weeks
💵 Average investment amount
$325
⏰ Last time a customer invested in ALT
185 days
ALT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
50%
Less than 50k
👶 Age of investors
18 - 25
50%
26 - 34
35 - 90
50%
🙋 Legal gender of investors
Female
100%
Male
Pearlers who invest in ALT also invest in...
🙌 Performance (5Yr p.a)
15.83%
📊 Share price
$44.97 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
50.71%
📊 Share price
$138.35 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
18.32%
📊 Share price
$598.46 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
518.51%
📊 Share price
$141.95 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
🙌 Performance (5Yr p.a)
30.60%
📊 Share price
$119.65 USD
📈 HIGH PRICE GROWTH